News Filter
News Articles List
The first patient has been dosed in a first-in-human phase 1/2 study evaluating DS-7300, an investigational B7-H3 targeting antibody drug conjugate...
NASHVILLE, TENN., May 30, 2019 – Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 100...